Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Charles River Laboratories announced the expansion of its service capabilities in early discovery screening.
read more
Thermo Fisher has signed agreements with Daiichi Sankyo and Takeda designed to expand the clinical utility of Oncomine Dx Target Test in support of clinical trials and drug development programs.
read more
Aerie Pharmaceuticals announced the appointment of Concetta Perro as Commercial Counsel, reporting to John LaRocca, Aerie’s General Counsel.
read more
ANI Pharmaceuticals has signed definitive agreements to acquire a portfolio of generic products and other assets from Amneal and Impax for undisclosed cash consideration.
read more
TheVax Genetics Vaccine and Biotechpharma have entered into a manufacturing agreement to produce THEVAX HBV vaccine for first-in-human clinical trials.
read more
Lyophilization Services of New England has acquired PSC Biotech’s cGMP aseptic fill finish manufacturing facility located in Madison, Wisconsin
read more
Lannett announced that effective July 1, 2018 current director, Patrick LePore, will become chairman of the board of directors, succeeding Jeffrey Farber, who will remain a member of the board.
read more
Scientist.com, the life science industry’s online marketplace for outsourced research, has launched DataSmart, a platform to ensure data and information integrity.
read more
Avella announced it has been selected by Otsuka to distribute Jynarque, the FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease.
read more
Pharma Tech Industries has hired Tu T. Tran as its new Vice President of Sales & Marketing.
read more
STA Pharmaceutical has signed an investment agreement with the government of Shanghai, Jinshan District to build a new R&D center.
read more
PAREXEL announced the appointment of Peyton Howell as Chief Commercial and Strategy Officer, effective May 7, 2018.
read more
Crown Bioscience has enhanced its existing portfolio of humanized drug target models by launching a new transgenic CD3E model to advance development of immuno-oncology drugs.
read more
Catalent announced organizational changes within its biologics business.
read more
Syringes for Pfizer’s epoetin biosimilar have been outfitted with Needle-Trap needle protection labels from Schreiner MediPharm.
read more